Traditional and Digital health therapies, together and mixed up.
Could digital medicine increase our life expectancy? Hopes (without hype) for a promising future.
Founder of iota Biosciences
Prof. Maharbiz’s research focuses on the extreme miniaturization of technology focused on building synthetic interfaces to cells and organisms. He is one of the inventors of “neural dust”, an ultrasonic interface for vanishingly small implants in the body, which led to the foundation of iota Biosciences, Inc. He has founded several successful companies, including Microreactor, Inc. and Cortera Neurotechnologies. In 2017 he received the McKnight Foundation’s Technological Innovations in Neuroscience Award; was named a Chan-Zuckerberg (CZ) Biohub Investigator in 2017; a Bakar Fellow in 2014 and is the recipient of a 2009 National Science Foundation CAREER Award, a GE Scholar and an Intel IMAP Fellow.
Categorías de conocimiento
Could digital medicine increase our life expectancy? Hopes (without hype) for a promising future.
If we can understand the brain, we will be able to address diseases and disorders that have so far eluded us.
Low Earth orbit (LEO) offers unique microgravity opportunities for research and technology advancement, as well as for developing new drugs through future space projects.